Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides

J Shanks, N Herring - American Journal of Physiology …, 2013 - journals.physiology.org
High levels of sympathetic drive in several cardiovascular diseases including
postmyocardial infarction, chronic congestive heart failure and hypertension are reinforced …

Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain

PC Rodriguez, DB Pereira… - Proceedings of the …, 2013 - National Acad Sciences
We recently introduced fluorescent false neurotransmitters (FFNs) as optical tracers that
enable the visualization of neurotransmitter release at individual presynaptic terminals …

Distinct modes of dopamine and GABA release in a dual transmitter neuron

M Borisovska, ASL Bensen, G Chong… - Journal of …, 2013 - Soc Neuroscience
We now know of a surprising number of cases where single neurons contain multiple
neurotransmitters. Neurons that contain a fast-acting neurotransmitter, such as glutamate or …

APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter

RJ Karpowicz Jr, M Dunn, D Sulzer… - ACS chemical …, 2013 - ACS Publications
We have previously introduced fluorescent false neurotransmitters (FFNs) as optical
reporters that enable visualization of individual dopaminergic presynaptic terminals and …

Extracellular α‐synuclein enters dopaminergic cells by modulating flotillin‐1–assisted dopamine transporter endocytosis

J Kobayashi, T Hasegawa, N Sugeno… - The FASEB …, 2019 - Wiley Online Library
The neuropathological hallmarks of Parkinson's disease (PD) include the appearance of α‐
synuclein (α‐SYN)‐positive Lewy bodies (LBs) and the loss of catecholaminergic neurons …

Ganglion-specific impairment of the norepinephrine transporter in the hypertensive rat

J Shanks, S Mane, R Ryan, DJ Paterson - Hypertension, 2013 - Am Heart Assoc
Hypertension is associated with enhanced cardiac sympathetic transmission, although the
exact mechanisms underlying this are still unknown. We hypothesized that defective function …

Angiotensin AT1 – α2C-Adrenoceptor Interaction Disturbs α2A-auto-Inhibition of Catecholamine Release in Hypertensive Rats

T Berg - Frontiers in Neurology, 2013 - frontiersin.org
α2-Adrenoceptors lower central sympathetic output and peripheral catecholamine release,
and thus may prevent sympathetic hyperactivity and hypertension. α2AR also influence …

[HTML][HTML] Dynamic monitoring of single-terminal norepinephrine transporter rate in the rodent cardiovascular system: a novel fluorescence imaging method

LL Cao, AP Holmes, JM Marshall, L Fabritz… - Autonomic …, 2020 - Elsevier
Here, we validate the use of a novel fluorescent norepinephrine transporter (NET) substrate
for dynamic measurements of transporter function in rodent cardiovascular tissue; this …

Mechanisms involved in nicotinic acetylcholine receptor-induced neurotransmitter release from sympathetic nerve terminals in the mouse vas deferens

DJ Williams, P Sidaway, TC Cunnane, KL Brain - PloS one, 2011 - journals.plos.org
Prejunctional nicotinic acetylcholine receptors (nAChRs) amplify postganglionic sympathetic
neurotransmission, and there are indications that intraterminal Ca2+ stores might be …

Resting cardiac sympathetic firing frequencies suppress terminal norepinephrine transporter uptake

LL Cao, JM Marshall, L Fabritz, KL Brain - Autonomic Neuroscience, 2021 - Elsevier
The prejunctional norepinephrine transporter (NET) is responsible for the clearance of
released norepinephrine (NE) back into the sympathetic nerve terminal. NET regulation …